Try our beta test site
1 study found for:    21228335 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed
Has Results
Oxaliplatin and Cetuximab in First-line Treatment of Metastatic Colorectal Cancer (mCRC)
Conditions: Neoplasm Metastasis;   Colorectal Cancer
Interventions: Biological: Cetuximab;   Drug: Oxaliplatin

Study has passed its completion date and status has not been verified in more than two years.